Differential expression and ligand binding properties of tumor necrosis factor receptor chimeric mutants
1Department of Cell Biology and Anatomy, Cornell University Medical College, New York, New York 10021.
Abstract:
The receptors for tumor necrosis factor (TNF) are represented by two transmembrane proteins, p55TNFR and p75TNFR, which are members of a family of cell surface molecules, including the Fas antigen, CD30, CD40, OX40, a Shope fibroma virus protein, and the low affinity p75 nerve growth factor receptor. A common structural feature is a sequence of 40 amino acids that is found in adjacent repeated domains, with 6 cysteine residues in a conserved register. To assess the functional significance of this cysteine-rich domain (CRD), we have constructed chimeric receptors between each TNF receptor and the low affinity nerve growth factor receptor. The chimeric receptor cDNAs were expressed efficiently in COS-1 and 3T3 fibroblasts, as assessed by affinity cross-linking, cell surface biotinylation and immunoprecipitation, and equilibrium binding. Receptors with two CRD of either TNF receptor were incapable of binding TNF, whereas receptors with all four CRD retained the ability to bind TNF with wild type affinity. These results, in conjunction with previous deletion mutation studies, suggest that TNF binding to each receptor requires all four cysteine-rich repeats. Furthermore, analysis of chimeric receptors containing domains of p55TNFR suggests that cytoplasmic sequences directly influence the levels of receptor expression.
Insights
Tumor necrosis factor (TNF) receptors require all four cysteine-rich repeats (CRDs) for TNF binding. Cytoplasmic sequences of the p55TNF receptor influence its expression levels.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Tumor necrosis factor (TNF) receptors (p55TNFR, p75TNFR) are transmembrane proteins crucial for immune responses.
- These receptors share structural homology with other cell surface molecules, featuring conserved cysteine-rich domains (CRDs).
Purpose of the Study:
- To investigate the functional significance of the cysteine-rich domains (CRDs) in TNF receptor binding and expression.
- To determine the minimal structural requirements for TNF binding to its receptors.
Main Methods:
- Construction of chimeric receptors combining TNF receptors with the low-affinity nerve growth factor receptor.
- Expression of chimeric receptors in COS-1 and 3T3 fibroblasts.
- Assessment of receptor expression and TNF binding using affinity cross-linking, cell surface biotinylation, immunoprecipitation, and equilibrium binding assays.
Main Results:
- Receptors with only two CRDs were unable to bind TNF.
- Receptors retaining all four CRDs bound TNF with wild-type affinity.
- Cytoplasmic domains of p55TNFR were found to regulate receptor expression levels.
Conclusions:
- TNF receptor binding necessitates the presence of all four cysteine-rich repeats.
- Cytoplasmic sequences play a direct role in modulating TNF receptor expression.
More Related Videos
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Receptor Tyrosine Kinases
TGF - β Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
